Transform Wealth LLC Sells 440 Shares of The Procter & Gamble Company (NYSE:PG)

Transform Wealth LLC trimmed its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 16.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,274 shares of the company’s stock after selling 440 shares during the quarter. Transform Wealth LLC’s holdings in Procter & Gamble were worth $375,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Alera Investment Advisors LLC raised its position in shares of Procter & Gamble by 1.2% in the first quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock valued at $812,000 after buying an additional 60 shares during the last quarter. Fiduciary Alliance LLC raised its holdings in Procter & Gamble by 2.8% in the 2nd quarter. Fiduciary Alliance LLC now owns 2,261 shares of the company’s stock valued at $371,000 after acquiring an additional 61 shares during the last quarter. Demars Financial Group LLC lifted its stake in shares of Procter & Gamble by 4.4% during the 4th quarter. Demars Financial Group LLC now owns 1,497 shares of the company’s stock worth $219,000 after purchasing an additional 63 shares during the period. LCM Capital Management Inc boosted its holdings in shares of Procter & Gamble by 1.1% during the first quarter. LCM Capital Management Inc now owns 5,701 shares of the company’s stock worth $925,000 after purchasing an additional 63 shares during the last quarter. Finally, Prentice Wealth Management LLC grew its position in shares of Procter & Gamble by 1.6% in the second quarter. Prentice Wealth Management LLC now owns 4,059 shares of the company’s stock valued at $669,000 after purchasing an additional 64 shares during the period. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Performance

Shares of PG opened at $167.01 on Tuesday. The company has a market cap of $394.17 billion, a price-to-earnings ratio of 27.26, a price-to-earnings-growth ratio of 3.64 and a beta of 0.41. The firm has a fifty day moving average of $166.93 and a 200-day moving average of $162.98. The Procter & Gamble Company has a 1 year low of $141.45 and a 1 year high of $171.72. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business had revenue of $20.53 billion during the quarter, compared to analyst estimates of $20.69 billion. During the same period in the prior year, the company posted $1.37 EPS. The business’s revenue for the quarter was down .1% compared to the same quarter last year. As a group, equities analysts anticipate that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.41%. Procter & Gamble’s dividend payout ratio is presently 65.85%.

Insider Buying and Selling

In other news, insider Moses Victor Javier Aguilar sold 9,149 shares of the company’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $167.72, for a total value of $1,534,470.28. Following the completion of the sale, the insider now owns 12,929 shares in the company, valued at $2,168,451.88. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at $1,902,451.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Moses Victor Javier Aguilar sold 9,149 shares of the company’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $167.72, for a total transaction of $1,534,470.28. Following the sale, the insider now directly owns 12,929 shares of the company’s stock, valued at $2,168,451.88. The disclosure for this sale can be found here. Insiders have sold a total of 125,462 shares of company stock valued at $21,238,114 over the last quarter. Corporate insiders own 0.17% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on PG. TD Cowen assumed coverage on shares of Procter & Gamble in a report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 target price for the company. Barclays lowered their price objective on shares of Procter & Gamble from $174.00 to $163.00 and set an “overweight” rating for the company in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft increased their target price on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Jefferies Financial Group lowered Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price target for the stock from $182.00 to $175.00 in a research note on Wednesday, July 24th. Finally, Stifel Nicolaus lifted their price objective on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. Nine analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average target price of $173.95.

Check Out Our Latest Research Report on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.